Details for New Drug Application (NDA): 050378
✉ Email this page to a colleague
NDA 050378 describes NEO-HYDELTRASOL, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the NEO-HYDELTRASOL profile page.
The generic ingredient in NEO-HYDELTRASOL is neomycin sulfate; prednisolone sodium phosphate. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; prednisolone sodium phosphate profile page.
The generic ingredient in NEO-HYDELTRASOL is neomycin sulfate; prednisolone sodium phosphate. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; prednisolone sodium phosphate profile page.
Summary for 050378
| Tradename: | NEO-HYDELTRASOL |
| Applicant: | Merck |
| Ingredient: | neomycin sulfate; prednisolone sodium phosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OPHTHALMIC | Strength | EQ 3.5MG BASE/GM;EQ 0.25% PHOSPHATE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
